Frost & Sullivan Life Science Expert Committee
Frost & Sullivan Expert Committee on
Life Sciences
2023year9month27On2023The Second New Investment Expo and the 17th Frost & Sullivan Global Growth, Innovation and Leadership Summit & New Investment Summit on Life Sciences were grandly held at the venue.
On September 27, 2023, the Appointment Ceremony of the Frost & Sullivan Expert Committee on Life Sciences was held during the Life Sciences New Investment Summit of the 2nd New Investment Expo and the 17th Frost & Sullivan Growth, Innovation and Leadership Summit.
21The century is the century of life sciences, and the development of life sciences is having a significant impact on all aspects of human life. From energy and environmental protection, to agriculture and the food industry, to medicine and health, biocomputers, and a series of industry issues related to human life may all find solutions through the development of life sciences.
The 21st century is the century of life sciences, and the development of life sciences is exerting significant influence on various aspects of human life. From energy and environmental protection to agriculture and food industry, and even to medicine and healthcare, as well as biocomputing, a series of industry-related issues pertaining to human life may find solutions through the development of life sciences.
Frost & Sullivan has been tracking and conducting in-depth research on the 'Life Sciences' track for a long time, publishing cutting-edge observations. This time, it has established a Life Sciences Expert Committee aiming to bring together authoritative institutions and cutting-edge scientific and technological innovation forces from industry, academia, research, capital, and policy-making circles. The committee focuses on helping the life sciences industry achieve high-quality development, innovation, and creativity. It jointly explores and promotes new paths and models for industry innovation and development. By jointly building an 'All-Region Investment Management' platform, the committee will leverage its respective resource advantages to jointly empower the development of the life sciences industry.
Frost & Sullivan has been conducting in-depth research on the "Life Sciences" track for a long time and has published cutting-edge observations. The establishment of the Expert Committee on Life Sciences aims to bring together authoritative institutions, cutting-edge science and technology innovation forces in industry, university, academia and capital circles to focus on supporting innovation and creativity in life sciences, high-quality industrial development, and jointly explore and promote new paths and new models of strategic transformation and innovative development.
The Committee will provide all-round support to LS through the co-construction of TIM ("Total Investment Management") and leveraging of their respective resource advantages.
The membership of the Frost & Sullivan Life Science Experts Committee is very comprehensive, including representatives from authoritative academic and research institutions in the field of life sciences, outstanding entrepreneurs from listed companies, representatives from investment institutions, and professionals from professional organizations.10Remaining senior professionals with industry influence
The Frost & Sullivan Expert Committee on Life Sciences is composed of over ten senior and influential professionals who have has made great accomplishments in various industries, Including representatives of notable listed companies, authoritative academic and research institutions, investment institutions, and professional bodies.
The specific list of members of the Frost & Sullivan Life Sciences Expert Committee is as follows:
The following is the list of the Frost & Sullivan Expert Committee on Life Sciences.:
Academician of the Russian Academy of Engineering, Co-founder of Jiangsu Puxin Biomedical Co., Ltd. Academician Zhang Dan
Academician Zhang Dan, Academician of the Russian Academy of Engineering, Co-founder of Jiangsu Hillgene
Director of Shanghai Biomedical Science and Technology Development Center Mr. Li Jizong
Li Jizong, Director of Shanghai Biomedical Technology Development Center
Dean and Deputy Secretary of the Shanghai Institute of Biotechnology, President of the Shanghai Biomedical Association Mr. Fu Daxu
Fu Daxu, President, Deputy Secretary of the Shanghai Institute for Biomedical Pharmaceutical Technologies, President of the Shanghai Biopharmaceutics Industry Association
Chief Medical Officer of Rongchang Biotech, Chief Scientist of SDIC Innovation Healthcare Dr. He Ruyi
He Ruyi, Chief Medical Officer of Rongchang Pharmaceuticals and Chief Scientist of SDIC Health Industry Investment
Executive Vice Chairman and Secretary-General of the China Biomedical Industry Chain Innovation and Transformation Alliance, and Chairman of the Nanjing Biomedical Industry Innovation and Transformation Center Professor Zheng Xiaonan
Prof. Zheng Xiaonan, Deputy Executive Director and Secretary-General of the CBIITA, President of the Nanjing Center for Innovation and Transformation in the Biopharmaceutical Industry
Meimes Law Firm, Managing Partner Mr. Geng Ke
Geng Ke, Managing Partner at O'Melveny & Myers LLP
EY Hong Kong Life Sciences & Healthcare Co-Head of the Greater China Region Mr. Feifan
Felix Fei, Co-Managing Partner of Life Sciences and Healthcare Industry at EY Greater China
Global Senior Vice President of BD Medical, General Manager of Greater China Region Mr. Deng Jianmin
Deng Jianmin, Global Senior Vice President and Greater China General Manager of BD (Becton, Dickinson and Company)
VP and Market Access Officer of Bristol-Myers Squibb Ms. Deng Yuxin
Deng Yuexin, Vice President and Head of Market Access of BMS (Bristol-Myers Squibb Company)
Deputy Director of Scientific Research and Second-level Researcher at Shanghai Institute of Immunology, Distinguished Professor at Shanghai Jiao Tong University Professor Li Bin
Li Bin, Researcher and Deputy Director of Scientific Research at Shanghai Institute of Immunology, Distinguished Professor of SJTU
Binling Venture Capital Management Partner Mr. Sun Xiaolu
Mr. Luke Sun, Managing Partner of Proxima Ventures
Co-Head of Investment Banking Healthcare Group and Managing Director of CITIC Securities Mr. Liu Xiaolan
Liu Xiaolan, Co-head and Managing Director of the Medical Group of CITIC Securities Investment Bank
*Rankings are not in any particular order.
It is reported that Frost & Sullivan Life Science Expert Committee Presided over by Academician Zhang Dan, with Mr. Li Jizong Served as Secretary-General of the Committee.
The Frost & Sullivan Expert Committee on Life Sciences is chaired by Academician Zhang Dan, with Mr. Li Jizong serving as the Secretary-General of the Committee.
At the appointment ceremony, Dr. Wang Xin, Global Partner and Chairman of Frost & Sullivan Greater China, Mr. Greg Carey, Partner at Frost & Sullivan, Global Head of Client Services and Senior Vice President, and others jointly Present appointment certificates to the expert committee members and take a group photo.
Neil Wang, Global Partner and Greater China Chairman of Frost & Sullivan, and Greg Caressi, Partner, Global Client Leader & SVP of Frost & Sullivan, presented appointment certificates to the expert committee members and took a group photo at the appointment ceremony.
Dr. Wang Xin and Mr. Greg Carey presented appointment letters to Academician Zhang Dan
Neil Wang, Dr. Greg Caressi and the academician Zhang Dan presented their appointment certificates
Dr. Wang Xin and Mr. Greg Carey presented the appointment letter to Mr. Li Jizong (received on behalf by Shi Tong).
Neil Wang and Greg Caressi presented their appointment letter to Mr. Li Jizong
(Authorized for collection: Ms. Shi Tong)
Dr. Wang Xin and Mr. Greg Carey presented the appointment certificate to Mr. Fu Daxu.
Neil Wang, Dr. Greg Caressi presented appointment letters to Fu Daxu
Why did Dr. Wang Xin and Mr. Greg Carey receive the appointment letter from Dr. Ruiyi?
Neil Wang, Dr. Greg Caressi and He Ruyi presented appointment certificates to him.
Dr. Wang Xin and Mr. Greg Carey presented appointment letters to Professor Zheng Xiaonan
Neil Wang, Dr. Greg Caressi and the team presented their appointment certificates to Professor Zheng Xiaonan
Dr. Wang Xin and Mr. Greg Carey presented the appointment certificate to Mr. Geng Ke.
Neil Wang, Dr. Greg Caressi and the appointment letter were presented to Mr. Geng Ke
Dr. Wang Xin and Mr. Greg Carey presented the appointment letter to Mr. Fei Fan
Neil Wang, Dr. Greg Caressi and Felix Fei presented their appointment certificates to Mr. Felix Fei
Dr. Wang Xin and Mr. Greg Carey presented the appointment certificate (issued by Jinni Auto) to Mr. Deng Jianmin.
Neil Wang, Dr. Greg Caressi and Mr. Deng Jianmin presented appointment certificates
(Authorized for collection: Mr. Jin Jia)
Dr. Wang Xin and Mr. Greg Carey presented the appointment certificate to Ms. Deng Yuexin (received on behalf by Xu Qingxiu).
Neil Wang, Ph.D. and Greg Caressi presented their appointment letter to Deng Yuexin
(Authorized for collection: Ms. Xu Qingxiu)
Dr. Wang Xin and Mr. Greg Carey presented appointment certificates to Professor Li Bin
Neil Wang, Dr. Greg Caressi and the team presented their appointment letter to Professor Li Bin
Dr. Wang Xin and Mr. Greg Carey presented appointment letters to Mr. Sun Xiaolu
Neil Wang, Dr. Greg Caressi and the team presented their appointment letter to Mr. Sun Xiaolu
Dr. Wang Xin and Mr. Greg Carey presented the appointment certificate to Mr. Liu Xiaolan
Neil Wang, Dr. Greg Caressi and Mr. Liu Xiaolan presented appointment certificates
In the future, the Frost & Sullivan Life Science Expert Committee will fully leverage its strengths and expertise, pool the wisdom of all sectors, empower the development of the life science industry, add value to corporate capital operations, serve national development, and jointly promote the high-quality development of the Chinese economy.
In the future, the Frost & Sullivan Expert Committee on Life Sciences will give full play to its strengths and expertise, gather wisdom from all walks of life, empower the development of the life sciences industry, generate value to the operation of corporate capital markets activities, and provide services to the development of the country in order to jointly promote the high-quality development of China's economy!
